Unknown

Dataset Information

0

Novel targeted therapies for metastatic breast cancer.


ABSTRACT: Metastatic breast cancer (mBC) continues to be a leading cause of cancer-related death in women. Even though mortality rates have improved over recent years, the 5-year survival rate of advanced BC is still at only 27%. As researchers and clinicians attempt to tackle this challenge, there has been extensive research and many trials studying treatment options for BC patients with metastatic disease, with numerous new therapies being discovered as a result. We review the most pertinent novel agents to enter the scope of BC treatment, including CDK4/6 inhibitors, PI3K inhibitors, mTOR inhibitors, immunotherapy, PARP inhibitors, and more.

SUBMITTER: Jazieh K 

PROVIDER: S-EPMC7396776 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel targeted therapies for metastatic breast cancer.

Jazieh Khalid K   Bell Ruth R   Agarwal Nayan N   Abraham Jame J  

Annals of translational medicine 20200701 14


Metastatic breast cancer (mBC) continues to be a leading cause of cancer-related death in women. Even though mortality rates have improved over recent years, the 5-year survival rate of advanced BC is still at only 27%. As researchers and clinicians attempt to tackle this challenge, there has been extensive research and many trials studying treatment options for BC patients with metastatic disease, with numerous new therapies being discovered as a result. We review the most pertinent novel agent  ...[more]

Similar Datasets

| S-EPMC4462184 | biostudies-literature
| S-EPMC7463725 | biostudies-literature
| S-EPMC3395896 | biostudies-other
| S-EPMC3195649 | biostudies-other
| S-EPMC2722050 | biostudies-other
| S-EPMC6095972 | biostudies-literature
| S-EPMC4569194 | biostudies-literature
| S-EPMC5347475 | biostudies-literature
| S-EPMC10497348 | biostudies-literature
| S-EPMC8395382 | biostudies-literature